Matchpoint Therapeutics
Matchpoint Therapeutics is a privately held biotechnology company headquartered in Watertown, Massachusetts — Cambridge at launch — that discovers precision small-molecule covalent medicines intended to transform the treatment of immune diseases and other serious illness. It was founded by covalent-chemistry, proteomics and computational-science researchers from Stanford University and Harvard Medical School, closed a $30 million seed round co-led by Atlas Venture and Access Biotechnology in November 2021, and launched publicly in October 2022 with $100 million in total financing after a $70 million Series A led by Sanofi Ventures with Vertex Ventures HC, Digitalis Ventures and Alexandria Venture Investments. Its proprietary Advanced Covalent Exploration (ACE) platform combines industry-leading chemoproteomics that detects allosteric, transient and cryptic binding pockets in native cells, machine-learning algorithms that prioritise targets and guide medicinal chemistry, and a continuously evolving proprietary library of covalent compounds spanning fragments through drug-like leads. In July 2025 Matchpoint entered an exclusive option and licence agreement with Novartis to develop oral covalent inhibitors against a transcription factor linked to multiple inflammatory diseases, worth up to $60 million upfront and in research funding and up to $1 billion in total potential payments. Matchpoint runs no developer program and publishes no product API, developer portal, API reference or SDK. The only machine-readable surface reachable without credentials is the WordPress REST content API behind matchpointtx.com, catalogued here.
Matchpoint Therapeutics publishes 9 APIs on the APIs.io network, including Comments API, Discovery API, Media API, and 6 more. Tagged areas include Company, Biotechnology, Pharmaceuticals, Drug Discovery, and Immunology.
Matchpoint Therapeutics’ developer surface includes authentication and 21 more developer resources.
Kin Score
APIs 9
Individual APIs this provider publishes, each with its own machine-readable definition.
Matchpoint Therapeutics Comments API
Comment collection. Registered and reachable, but empty — no object on this deployment carries comments.
Matchpoint Therapeutics Discovery API
Route, type, taxonomy and status discovery documents.
Matchpoint Therapeutics Media API
Media library — 43 image attachments at harvest time.
Matchpoint Therapeutics Oembed API
oEmbed 1.0 provider endpoint for matchpointtx.com URLs.
Matchpoint Therapeutics Pages API
Corporate pages — homepage, privacy policy, terms of use (3 published at harvest time).
Matchpoint Therapeutics Posts API
News archive — company press releases and third-party coverage (5 published at harvest time).
Matchpoint Therapeutics Search API
Cross-content search across published objects.
Matchpoint Therapeutics Taxonomy API
Categories, post tags and the team_types taxonomy. Only one category term exists; post_tag and team_types are registered but empty.
Matchpoint Therapeutics Team API
Leadership, board, observers and scientific founders as a custom post type (19 published at harvest time).
Scroll for all 9
Pricing Plans 1
Published pricing tiers and plan structures.
Rate Limits 1
Documented rate limits and quota policies.
Matchpoint Therapeutics Rate Limits
RATE LIMITSSecurity Posture 2
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 2
MCP servers, agent skills, and machine-readable catalogs
Design & Contract 5
Pagination, idempotency, versioning, errors, and events
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 2
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 3
Pricing, plans, and the legal terms of use
Company 5
The organization behind the API
Other 3
Properties that don't map to a standard resource type
Source (apis.yml)
Work with this as data
Every provider here is available over the APIs.io API and to AI agents over MCP.